Vir Biotechnology Inc (VIR) earnings · rev $68.6M
These earnings events as JSON? API free 100/dayVir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
This VIR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported VIR revenue for 2025-12-31 was $68.6M. Net income was -$438.0M. Revenue was down 7.6% from 2024-12-31 to 2025-12-31. VIR currently screens at market cap $1.45B.
When the next VIR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 7.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full VIR research stays on the stock page; the tape stays on the quote page.
VIR earnings FAQ
What are VIR's latest revenue and net income?
Latest cached Vir Biotechnology Inc (VIR) revenue for Dec 31, 2025 was $68.6M. Net income was -$438.0M. Statements: https://lician.com/financials/vir
What is VIR's latest diluted EPS?
Latest cached Vir Biotechnology Inc (VIR) diluted EPS for Dec 31, 2025 was -$3.16.
What period does the latest VIR earnings print cover?
The latest cached Vir Biotechnology Inc (VIR) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did VIR revenue change from the prior cached period?
Cached Vir Biotechnology Inc (VIR) revenue was down 7.6% from $74.2M (Dec 31, 2024) to $68.6M (Dec 31, 2025). Statements: https://lician.com/financials/vir
Where are VIR earnings listed?
Cached earnings facts for Vir Biotechnology Inc (VIR) are listed at https://lician.com/earnings/vir. Statements: https://lician.com/financials/vir
Not investment advice.